Wednesday, August 20, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Provide Mixed Ratings and Price Targets for Pactiv Evergreen

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finances (2)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On March 4, 2024, Goldman Sachs analyst Adam Samuelson reiterated a Neutral rating on Pactiv Evergreen (NASDAQ: PTVE) and raised the price target to $14, up from $12.5. This adjustment marks a series of updates that have seen the price target climb from $11 to $12.5 previously.

Other analysts have also weighed in on PTVE, offering a range of price targets. The average among them is $16.58, with the highest forecast coming in at $19.00. Baird analyst Ghansham Panjabi has similarly maintained a Neutral rating on PTVE, but has upped the price target to $12.

[bs_slider_forecast ticker=”PTVE”]

PTVE Stock Price Plummets by 10%: What Investors Need to Know

On March 4, 2024, PTVE stock experienced a significant drop in price, closing at $13.26, a decrease of $1.49 or 10.10% from the previous market close. Furthermore, in pre-market trading, the stock dropped an additional $0.25.

Investors who were holding PTVE shares may have been taken aback by this sudden drop in price. It is important to note that stock prices can be influenced by a variety of factors, including market conditions, company performance, and investor sentiment. In this case, it appears that something may have caused investors to sell off their PTVE shares, leading to the sharp decline in price.

For investors considering buying or selling PTVE stock, it is essential to conduct thorough research and analysis to understand the reasons behind the price drop and determine whether it is a temporary dip or a sign of more significant issues with the company. Keeping an eye on market trends and news related to PTVE can help investors make informed decisions about their investments.

Currently Playing

PTVE Stock Reports Mixed Performance in Financial Results for 2024: Revenue and Net Income Decrease

On March 4, 2024, PTVE stock experienced a mixed performance as the company reported its financial results for the past year and the fourth quarter. According to data from CNN Money, PTVE’s total revenue for the year was $5.51 billion, which represented a decrease of 11.41% compared to the previous year. The total revenue for the fourth quarter was $1.27 billion, which remained flat compared to the previous quarter. PTVE reported a loss of $223.00 million for the year, which was a significant decrease of 170.13% compared to the previous year. The net income for the fourth quarter was $21.00 million, which also decreased by 22.22% compared to the previous quarter. Earnings per share (EPS) for PTVE were reported at -$1.26 for the year, representing a decrease of 171.4% compared to the previous year. The EPS for the fourth quarter was $0.11, which remained flat compared to the previous quarter. Overall, PTVE’s financial performance on March 4, 2024, showed a decrease in total revenue and net income compared to the previous year. However, the company was able to maintain its total revenue and net income at the same level compared to the previous quarter. The decrease in EPS for the year was significant, but the EPS for the fourth quarter remained stable. Investors and analysts will likely closely monitor PTVE’s future financial performance to assess the company’s ability to rebound from the recent declines and drive growth in the coming quarters. It will be crucial for PTVE to implement strategic measures to improve its financial metrics and regain investor confidence in the stock.

[stock_market_chart symbol=”PTVE” range=”3mo” interval=”1d” settings='{“primaryChartType”:”smoothedLine”,”secondaryChartType”:”column”,”width”:”100%”,”height”:”500px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:14,”color”:”#383838″,”primaryLineColor”:”#5679ff”,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#5679ff”,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#020202″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#e8e8e8″,”scrollbarSelectedBackgroundColor”:”#f7f7f7″,”scrollbarGraphFillColor”:”#435dc2″,”scrollbarSelectedGraphFillColor”:”#92a8fc”,”primaryLineThickness”:2,”secondaryLineThickness”:1,”gridThickness”:1,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”searchMode”:”search”,”mouseWheelZoomEnabled”:false,”cursorEnabled”:true,”exportEnabled”:true,”scrollbarEnabled”:true,”legendEnabled”:true,”periods”:”1D,1M,YTD,ALL”,”defaultPeriod”:”1M”}’]

Tags: PTVE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Financial Performance of Jasper Therapeutics for the Year Ending December 31 2023

Finance_ projections

Financial Analysts Bullish on Li Auto Stock

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Lyfts Stock Rises After Upgrade from RBC Capital

Recommended

Alternative Energy Markets and money

NextDecade Corporations Strategic Growth and Construction Update

1 year ago
Biomedicine plant based

Cantor Fitzgerald Analyst Maintains Neutral Rating on KLA Corporation

2 years ago
Finance_Fiscal (1)

Cardlytics Announces Groundbreaking Settlement Agreement and Positive Financial Results

2 years ago
Real Estate Investment Markets and money

W P Careys Strategic Sale of State of Andalusia Portfolio Positions Company for Growth

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NIO NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

A Watershed Moment for 374Water in the Battle Against ‘Forever Chemicals’?

PulteGroup Stock: Navigating Strong Fundamentals and Market Headwinds

Leadership Turmoil at Opendoor Sparks Market Volatility

Clinical Timeline Concerns Overshadow Erasca’s Financial Progress

LendingClub’s Impressive Growth Meets Unexpected Market Skepticism

Clean Energy Fuels Navigates a Mixed Outlook in the Renewable Gas Sector

Trending

Adobe Stock
Stocks

Adobe’s AI Ambition Meets Investor Skepticism

by Felix Baarz
August 20, 2025
0

While Adobe makes significant strides in artificial intelligence with its newly unveiled Acrobat Studio, a curious divergence...

ASML Stock

ASML Shares Navigate Crosscurrents of AI Demand and Geopolitical Strain

August 20, 2025
Take-Two Stock

Take-Two Stock: Strong Fundamentals Clash With Market Uncertainty

August 20, 2025
374Water Common Stock Stock

A Watershed Moment for 374Water in the Battle Against ‘Forever Chemicals’?

August 20, 2025
PulteGroup Stock

PulteGroup Stock: Navigating Strong Fundamentals and Market Headwinds

August 20, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Adobe’s AI Ambition Meets Investor Skepticism August 20, 2025
  • ASML Shares Navigate Crosscurrents of AI Demand and Geopolitical Strain August 20, 2025
  • Take-Two Stock: Strong Fundamentals Clash With Market Uncertainty August 20, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com